[1]邢时龙,淦 勤.原发性肝癌患者血清25-羟基维生素D3水平与免疫抑制因子IL-10的关系[J].医学信息,2020,33(01):101-103.[doi:10.3969/j.issn.1006-1959.2020.01.030]
　XING Shi-long,GAN Qin.Relationship Between Serum 25-hydroxyvitamin D3 Level and Immunosuppressive Factor IL-10 in Patients with Primary Liver Cancer[J].Medical Information,2020,33(01):101-103.[doi:10.3969/j.issn.1006-1959.2020.01.030]
点击复制

原发性肝癌患者血清25-羟基维生素D3水平与免疫抑制因子IL-10的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年01期
页码:
101-103
栏目:
论著
出版日期:
2020-01-01

文章信息/Info

Title:
Relationship Between Serum 25-hydroxyvitamin D3 Level and Immunosuppressive Factor IL-10 in Patients with Primary Liver Cancer
文章编号:
1006-1959（2020）01-00101-03
作者:
邢时龙; 淦 勤
（九江市第一人民医院肝胆外科，江西 九江 332000）
Author(s):
XING Shi-long; GAN Qin
(Department of Hepatobiliary Surgery,Jiujiang First People’s Hospital,Jiujiang 332000,Jiangxi,China)
关键词:
原发性肝癌; 25-（OH）D3; IL-10
Keywords:
Primary liver cancer; 25- (OH) D3; IL-10
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2020.01.030
文献标志码:
A
摘要:
目的 探究原发性肝癌患者血清25-羟基维生素D3[25-（OH）D3]的变化及其与免疫抑制因子IL-10的关系。方法 选取2014年2月~2019年7月于我院就诊的60例原发性肝癌患者作为疾病组，另外选择同期60名健康体检人群作为健康对照组，采用电化学发光法测定两组血清25-（OH）D3浓度，酶联免疫吸附试验测定血清IL-10浓度。Spearman法分析25-（OH）D3与IL-10间的相关性。结果 疾病组血清25-（OH）D3浓度低于健康对照组[（13.65±7.92）ng/ml vs （26.15±8.33）ng/ml]，差异有统计学意义（P＜0.05）；疾病组IL-10浓度高于健康对照组[（89.71±26.59）ng/ml vs （26.18±8.15）ng/ml]，差异有统计学意义（P＜0.05）。血清25-（OH）D3可能与淋巴结转移和肿瘤分期密切相关，与IL-10浓度呈负相关（r=-0.568，P＜0.05）。结论 原发性肝癌患者存在25-（OH）D3缺乏现象，且与肿瘤进展和免疫抑制密切相关。
Abstract:
Objective To investigate the changes of serum 25-hydroxyvitamin D3[25-(OH)D3] in patients with primary liver cancer and its relationship with the immunosuppressive factor IL-10.Methods 60 patients with primary liver cancer who were treated in our hospital from February 2014 to July 2019 were selected as the disease group, and another 60 healthy people were selected as the healthy control group during the same period,the serum 25-(OH)D3 concentration was measured by electrochemical luminescence method, and the serum IL-10 concentration was determined by ELISA. Spearman’s method was used to analyze the correlation between 25-(OH)D3 and IL-10.Results The serum 25-(OH)D3 concentration in the disease group was(13.65±7.92) ng/ml, which was lower than that in the healthy control group(26.15±8.33) ng/ml, the difference was statistically significant (P<0.05); the IL-10 in the disease group the concentration was higher than that in the healthy control group [(89.71±26.59) ng/ml vs (26.18±8.15) ng/ml],the difference was statistically significant(P<0.05). Serum 25-(OH)D3 may be closely related to lymph node metastasis and tumor stage, and negatively correlated with IL-10 concentration(r=-0.568,P<0.05). Conclusion 25-(OH)D3 deficiency exists in patients with primary liver cancer, and is closely related to tumor progression and immunosuppression.

参考文献/References:

[1]Siegel RL,Miller KD,Jemal A.Cancer Statistics,2017[J].CA Cancer J Clin,2017(67):7-30. [2]季盛,卓蕴慧.221例乙型肝炎相关性肝癌患者的流行病学分析[J].肝脏,2012,17(12):865-866. [3]张典,姜凤良,胡志芳,等.原发性肝癌的预防措施[J].中国老年学杂志,2018,38(17):4317-4319. [4]Kumari R,Sahu MK,Tripathy A,et al.Hepatocellular carcinoma treatment: hurdles, advances and prospects[J].Hepat Oncol,2018,5(2):HEP08. [5]Peters MG.Hepatitis B Virus Infection:What Is Current and New[J].Top Antivir Med,2019,26(4):112-116. [6]Skrajnowska D,Bobrowska-Korczak B.Potential Molecular Mechanisms of the Anti-cancer Activity of Vitamin D[J].Anticancer Res,2019,39(7):3353-3363. [7]Said E,Agawy WE,Ahmed R,et al.Serum Vitamin D Levels in Treatment-na?觙ve Chronic Hepatitis B Patients[J].Journal of Translational Internal Medicine,2017,5(4):230-234. [8]陶一明,冯铁诚,王志明.原发性肝癌患者TNM 分期与术后生存关系:SEER 数据库分析[J].中国普通外科杂志,2016,25(7):952-956. [9]文天夫.原发性肝癌诊疗规范（2017年版）解读[J].中国普外基础与临床杂志,2018(1):32-34. [10]Chirumbolo S.Vitamin D3 in cancer prevention and therapy: the nutritional issue[J].Hormone Molecular Biology and Clinical Investigation,2015,23(3):71-78. [11]Kennel KA,Drake MT.Vitamin D in the cancer patient[J].Current Opinion in Supportive and Palliative Care,2013,7(3):272-277. [12]Finkelmeier F,Kronenberger B, KoBerle V,et al.Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study[J].Alimentary Pharmacology & Therapeutics,2014,39(10):1204-1212. [13]祁晓平,李培,恽时峰,等.1,25-二羟基25-(OH)D3对致死剂量脂多糖攻击的大鼠CD4＋CD25＋Treg细胞的调节作用[J].中国现代普通外科进展,2011,14(9):676-679. [14]刘勇,周彪,曾金,等.肝癌患者外周血Th17/Treg细胞和相关细胞因子的表达及IL-17对肝癌细胞侵袭的影响[J].中国老年学杂志,2018,38(3):700-702. [15]康慧琴,孟娟,行超然,等. 慢性丙肝及肝硬化患者外周血Th17/Treg细胞及其相关细胞因子的表达及意义[J]. 中国医药科学,2017,7(15):248-251.

相似文献/References:

[1]张 黎.中晚期原发性肝癌介入治疗的临床效果及对 肝功能的影响[J].医学信息,2018,31(09):20.[doi:10.3969/j.issn.1006-1959.2018.09.006]
　ZHANG Li.The Clinical Effect of Interventional Treatment of Primary Liver Cancer in Middle and Late Stage and its Effect on Liver Function[J].Medical Information,2018,31(01):20.[doi:10.3969/j.issn.1006-1959.2018.09.006]
[2]朱 瑞.血清AFP、CA19-9、CEA单项及三者联合检验对原发性肝癌早期诊断与治疗的意义对比[J].医学信息,2018,31(13):154.[doi:10.3969/j.issn.1006-1959.2018.13.047]
　ZHU Rui.Comparison of the Significance of Serum AFP,CA19-9,CEA Single and Combined the Three Methods Tests in the Early Diagnosis and Treatment of Primary Liver Cancer[J].Medical Information,2018,31(01):154.[doi:10.3969/j.issn.1006-1959.2018.13.047]
[3]侯宝松,王海峰,徐海晶,等.大黄蛰虫方合逍遥方加减对原发性肝细胞癌 TACE术后综合征影响[J].医学信息,2018,31(14):53.[doi:10.3969/j.issn.1006-1959.2018.14.017]
　HOU Bao-song,WANG Hai-feng,XU Hai-jing,et al.Effect of Rhubarb Aphid Fanghe Xiaoyaofang Decoction on Postoperative TACE Syndrome of Primary Hepatocellular Carcinoma[J].Medical Information,2018,31(01):53.[doi:10.3969/j.issn.1006-1959.2018.14.017]
[4]郑德仁.多排螺旋CT诊断肝血管瘤及肝脏肿瘤的临床价值分析[J].医学信息,2018,31(20):160.[doi:10.3969/j.issn.1006-1959.2018.20.050]
　ZHENG De-ren.Clinical Value of Multi-slice Spiral CT in Diagnosis of Hepatic Hemangioma and Liver Tumor[J].Medical Information,2018,31(01):160.[doi:10.3969/j.issn.1006-1959.2018.20.050]
[5]赵鱼扉,史政荣.肝脏储备功能临床应用研究[J].医学信息,2019,32(10):35.[doi:10.3969/j.issn.1006-1959.2019.10.013]
　ZHAO Yu-fei,SHI Zheng-rong.Clinical Application of Liver Reserve Function[J].Medical Information,2019,32(01):35.[doi:10.3969/j.issn.1006-1959.2019.10.013]
[6]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Medical Information,2019,32(01):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[7]王瑞航,姚升娟,张 晨,等.肝动脉化疗栓塞介入术对原发性肝癌患者近期疗效及Child-Pugh分级的影响[J].医学信息,2020,33(17):101.[doi:10.3969/j.issn.1006-1959.2020.17.029]
　WANG Rui-hang,YAO Sheng-juan,ZHANG Chen,et al.Effect of Interventional Hepatic Artery Chemoembolization on the Short-term Efficacy and Child-Pugh Classification of Patients with Primary Liver Cancer[J].Medical Information,2020,33(01):101.[doi:10.3969/j.issn.1006-1959.2020.17.029]
[8]郑澹宁,孙国平.肝动脉化疗栓塞的肝癌患者生活质量调查研究[J].医学信息,2020,33(22):127.[doi:10.3969/j.issn.1006-1959.2020.22.036]
　ZHENG Dan-ning,SUN Guo-ping.Survey on the Quality of Life of Hepatocellular Cancer Patients Undergoing Transcatheter Arterial Chemoembolization[J].Medical Information,2020,33(01):127.[doi:10.3969/j.issn.1006-1959.2020.22.036]
[9]包学智.经肝动脉化疗栓塞联合射频消融术治疗中晚期原发性肝癌的效果[J].医学信息,2020,33(19):110.[doi:10.3969/j.issn.1006-1959.2020.19.033]
　BAO Xue-zhi.The Effect of Transhepatic Artery Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Advanced Primary Liver Cancer[J].Medical Information,2020,33(01):110.[doi:10.3969/j.issn.1006-1959.2020.19.033]
[10]郑春榕,阮清发.康氏学术流派在原发性肝癌治疗中的经验拾萃[J].医学信息,2021,34(05):169.[doi:10.3969/j.issn.1006-1959.2021.05.049]

更新日期/Last Update: 2020-01-01